ArticlePharmaceutics2025

In Situ Targeting RGD-Modified Cyclodextrin Inclusion Complex/Hydrogel Hybrid System for Enhanced Glioblastoma Therapy.

Xiaofeng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.